Smart algorithm could tailor blood thinner use for heart patients
NCT ID NCT05732701
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 30 times
Summary
This study tests whether a personalized algorithm can determine the best length of time for patients to take two blood thinners after getting a heart stent. About 2,788 adults who have had a stent placed will be assigned to either standard care or algorithm-guided treatment. The goal is to reduce both bleeding and heart-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Cardiology, Bern University Hospital
RECRUITINGBern, 3010, Switzerland
Contact
-
UOC Cardiologia San Giovanni Addolorata Hospital
RECRUITINGRoma, 00184, Italy
Contact Email: •••••@•••••
-
University Clinical Center of the Republic of Srpska
RECRUITINGBanja Luka, 78000, Bosnia and Herzegovina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.